Shares in vaccine makers including Moderna and BioNTech rose sharply on Wednesday after Australia reported its first human H5N1 bird flu case and the US detected its third, increasing fears of wider transmission.
周三，莫德納(Moderna)和BioNTech等疫苗制造商股價大幅上漲。此前，澳大利亞報告了該國首例人感染H5N1禽流感病例，隨后美國發現該國第三例，這加劇了人們對這種疾病更廣泛傳播的擔憂。
您已閱讀6%（308字），剩余94%（4487字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。